Advanced in Liver Failure

Dr. Gyongyi Szabo

Gastroenterology
330 Brookline Ave, 
Boston, MA 
Accepting New Patients
36 Years of Experience
Advanced in Liver Failure
330 Brookline Ave, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Gyongyi Szabo is a Gastroenterologist in Boston, Massachusetts. Dr. Szabo has been practicing medicine for over 36 years and is rated as an Advanced provider by MediFind in the treatment of Liver Failure. Her top areas of expertise are Hepatitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Colonoscopy. Dr. Szabo is currently accepting new patients.

Her clinical research consists of co-authoring 258 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 21 articles in the study of Liver Failure.

Specialties
Gastroenterology
Licenses
Internal Medicine in MA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO

Locations

330 Brookline Ave, Boston, MA 02215

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

257 Total Publications

Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
Journal: Nature reviews. Gastroenterology & hepatology
Published: August 28, 2025
Similar Doctors
Distinguished in Liver Failure
Dr. Michael A. Fuchs
Gastroenterology
Distinguished in Liver Failure
Dr. Michael A. Fuchs
Gastroenterology
45 Francis Street, Asb-ii, 
Boston, MA 
 (0.3 miles away)
617-732-6389
Languages Spoken:
English
See accepted insurances

Michael Fuchs is a Gastroenterologist in Boston, Massachusetts. Dr. Fuchs is rated as a Distinguished provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Classical Hodgkin Lymphoma, Liver Failure, Knee Replacement, and Liver Transplant.

Advanced in Liver Failure
Dr. Matthew Rockacy
Gastroenterology
Advanced in Liver Failure
Dr. Matthew Rockacy
Gastroenterology

St. Joseph Hospital Of Nashua Nh

168 Kinsley St, 
Nashua, NH 
 (34.2 miles away)
603-598-0455
Languages Spoken:
English
See accepted insurances

Matthew Rockacy is a Gastroenterologist in Nashua, New Hampshire. Dr. Rockacy is rated as a Distinguished provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Irritable Bowel Syndrome (IBS), Visceromegaly, Trichohepatoenteric Syndrome, Gastrectomy, and Colonoscopy.

Advanced in Liver Failure
Dr. Melissa Minor
Gastroenterology
Advanced in Liver Failure
Dr. Melissa Minor
Gastroenterology

Mass General Brigham Medical Group Northern Massachusetts Inc

55 Highland Ave, 
Salem, MA 
 (15.7 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Melissa Minor is a Gastroenterologist in Salem, Massachusetts. Dr. Minor is rated as an Advanced provider by MediFind in the treatment of Liver Failure. Her top areas of expertise are Liver Failure, Hepatitis, Turcot Syndrome, Colonoscopy, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Szabo's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile